4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000899243-20-001261
Options or other derivatives
- Director acquired 24,264 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Miller-Rich Nancy Director | 2020-01-13 | Grant or award · Stock Option (Right to Buy) | +24,264 | 24,264 | D | ||
Loading xslF345X03/doc4.xml…